Whether you're on brand-name Ozempic, Wegovy, or compounded semaglutide, the tracking needs are the same: injection schedule, weight trend, side effects, sleep, mood, and nutrition — all connected by AI. That's tr8ck.
Semaglutide is a GLP-1 receptor agonist that mimics the body's natural incretin hormone, slowing gastric emptying, reducing appetite, and promoting feelings of fullness. It's the same molecule whether you're injecting Ozempic for diabetes, Wegovy for weight management, or a compounded version from a pharmacy — the tracking approach is identical.
Dose escalation: 0.25 mg → 0.5 mg → 1 mg → 2 mg. Primary indication is blood glucose management in type 2 diabetes. Many users also experience significant weight loss. Track injection day, dose, weight, and glucose-relevant metrics alongside sleep and mood.
Dose escalation: 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg. Approved specifically for chronic weight management. The 2.4 mg maintenance dose is higher than Ozempic's maximum. Primary tracking focus is weight trend, protein intake, and muscle preservation.
Compounded semaglutide is pharmacy-manufactured and may use different dose increments than brand-name products. tr8ck's medication module accepts custom dose amounts, making it fully compatible. Same tracking approach applies: injection schedule, side effects, weight, sleep, mood, and nutrition.
Each escalation step brings different side effect patterns and different weight loss rates. Tracking gives you a data history of exactly how your body responded at each level.
| Dose (Wegovy) | Weeks | Key tracking focus | Typical experience |
|---|---|---|---|
| 0.25 mg | 1–4 | Establish nausea/energy baseline | Tolerability dose — minimal appetite change |
| 0.5 mg | 5–8 | Side effect severity, sleep quality | First noticeable appetite suppression |
| 1 mg | 9–12 | Weight trend, protein intake | Stronger suppression; nausea often peaks here |
| 1.7 mg | 13–16 | Muscle retention, exercise capacity | Side effects often improved; weight loss accelerates |
| 2.4 mg | 17+ | Long-term trend, plateau risk | Maximum dose; shift to maintenance focus |
Several apps target GLP-1 users. Here's how they compare on the metrics that matter for semaglutide tracking.
| Feature | Shotsy | Pep | Glapp | tr8ck |
|---|---|---|---|---|
| Injection logging | ✓ | ✓ | ✓ | ✓ + rotation tracking |
| Weight tracking | Basic | ✓ | ✓ | ✓ + 4-week average |
| Sleep module | ✗ | ✗ | ✗ | ✓ Full module |
| Mood tracking | ✗ | Limited | ✗ | ✓ Daily scoring |
| Nutrition + protein | ✗ | ✗ | Basic calories | ✓ Full nutrition module |
| AI cross-module insights | ✗ | ✗ | ✗ | ✓ Correlates all modules |
| Compound semaglutide support | ✓ | Partial | ✗ | ✓ Custom doses |
| Exercise tracking | ✗ | ✗ | ✗ | ✓ Full module |
| Free to use | Paid | Paid | Paid | ✓ Free early access |
Weight is the primary goal — but semaglutide changes much more. Tracking the full picture turns confusing experiences into understandable patterns.
GI symptoms disrupt sleep in the days after injection. Long-term, weight loss from semaglutide often substantially improves sleep quality — particularly for users with sleep apnea. Tracking both the short-term disruptions and long-term trend gives you the complete picture.
GLP-1 receptors exist throughout the brain, including reward and mood centers. Many users report reduced food noise and improved wellbeing. Some experience emotional blunting or anxiety during escalation. Daily mood logging reveals your personal response — valuable clinical data.
Appetite suppression is the primary mechanism — but it can cause undereating. Tracking protein intake protects muscle mass. Tracking calorie intake ensures you're eating enough to maintain metabolism. The goal is not the lowest possible intake, but the right composition.
Energy levels follow the injection cycle. Post-injection fatigue is common in early weeks; improved energy as body adapts is common by months 2–3. Logging energy by injection cycle day shows your personal rhythm and when you're best positioned for demanding exercise.
Both contain semaglutide, but Wegovy reaches a higher maximum dose (2.4 mg vs 2 mg for Ozempic) and is specifically approved for weight management. The core tracking approach is identical — injection schedule, weight, sleep, mood, nutrition. Ozempic users managing diabetes may also want to note glucose-related context. tr8ck handles both in the same app.
tr8ck's medication module accepts custom dose amounts, making it fully compatible with compounded semaglutide at any concentration. The same correlation features apply regardless of source: your weight trend, sleep quality, mood, and nutrition data are all connected to your injection history automatically.
Log your current dose in the medication module and update it each escalation. Wegovy escalates every 4 weeks: 0.25 → 0.5 → 1 → 1.7 → 2.4 mg. tr8ck maps your symptoms, sleep quality, and weight trend against dose history so you can see exactly how each escalation step affected you — and share that data with your prescriber if needed.
Yes — in two directions. Short-term: GI symptoms disrupt sleep in the 2–4 days after injection, especially during escalation. Long-term: the weight loss from semaglutide often substantially improves sleep quality for users with obesity-related sleep disorders. Tracking both reveals the full picture.
Track from day one and continue for the full treatment duration. Early tracking (weeks 1–12) captures your side effect patterns and dose escalation responses. Mid-term tracking (months 3–12) reveals weight loss trends, plateaus, and behavioral correlations. Long-term tracking catches protein drift, sleep changes, and early signs of plateau before they compound.
Free during early access. All 13 modules. Works for Ozempic, Wegovy, and compound semaglutide.
Try tr8ck FreeAlso worth reading